AKI India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 29, 2025, 11:16 pm

Quick Insight

AKI India Ltd, operating in the footwear industry, currently trades at ₹10.0 with a market capitalization of ₹103 Cr. The company's P/E ratio stands at 77.6, significantly higher than the sector average of around 30x, indicating a premium valuation. AKI India's Return on Equity (ROE) at 1.80% and Return on Capital Employed (ROCE) at 4.54% are relatively low compared to industry peers, suggesting inefficiency in capital utilization. Additionally, the negative Operating Profit Margin (OPM) of -0.62% raises concerns about the company's ability to generate profits from its core operations. On a positive note, the company boasts a healthy Interest Coverage Ratio (ICR) of 3.36x, indicating its ability to service debt obligations comfortably.

However, AKI India faces risks due to its high P/E ratio, indicating a potentially overvalued stock, and the low ROE and ROCE figures, signaling operational inefficiencies that could hinder long-term growth. Furthermore, the company's high level of borrowings at ₹19.17 Cr compared to its reserves of ₹47.18 Cr raises concerns about its leverage position. Looking ahead, AKI India's outlook could improve if the company focuses on enhancing operational efficiency to boost profitability and reduces its reliance on borrowings to strengthen its balance sheet resilience. Conversely, a worsening economic environment could exacerbate the company's challenges, leading to further pressure on its financial performance.

In conclusion, while AKI India Ltd exhibits certain strengths such as a solid interest coverage ratio, investors should carefully assess the company's operational efficiency and valuation metrics before making investment decisions. Monitoring the company's efforts to improve profitability and manage debt levels will be crucial in determining its future performance and sustainability in the competitive footwear industry.

Competitors of AKI India Ltd

All Competitor Stocks of AKI India Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:10 am

Below is a detailed analysis of the quarterly data for AKI India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 11.36 Cr.. The value appears to be declining and may need further review. It has decreased from 17.05 Cr. (Mar 2025) to 11.36 Cr., marking a decrease of 5.69 Cr..
• For Expenses, as of Jun 2025, the value is 11.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 17.91 Cr. (Mar 2025) to 11.43 Cr., marking a decrease of 6.48 Cr..
• For Operating Profit, as of Jun 2025, the value is -0.07 Cr.. The value appears strong and on an upward trend. It has increased from -0.86 Cr. (Mar 2025) to -0.07 Cr., marking an increase of 0.79 Cr..
• For OPM %, as of Jun 2025, the value is -0.62%. The value appears strong and on an upward trend. It has increased from -5.04% (Mar 2025) to -0.62%, marking an increase of 4.42%.
• For Other Income, as of Jun 2025, the value is 1.29 Cr.. The value appears to be declining and may need further review. It has decreased from 2.41 Cr. (Mar 2025) to 1.29 Cr., marking a decrease of 1.12 Cr..
• For Interest, as of Jun 2025, the value is 0.51 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.62 Cr. (Mar 2025) to 0.51 Cr., marking a decrease of 0.11 Cr..
• For Depreciation, as of Jun 2025, the value is 0.40 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.50 Cr. (Mar 2025) to 0.40 Cr., marking a decrease of 0.10 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 0.43 Cr. (Mar 2025) to 0.31 Cr., marking a decrease of 0.12 Cr..
• For Tax %, as of Jun 2025, the value is 32.26%. The value appears to be improving (decreasing) as expected. It has decreased from 72.09% (Mar 2025) to 32.26%, marking a decrease of 39.83%.
• For Net Profit, as of Jun 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.12 Cr. (Mar 2025) to 0.21 Cr., marking an increase of 0.09 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.02. The value appears strong and on an upward trend. It has increased from 0.01 (Mar 2025) to 0.02, marking an increase of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:07 pm

Growth

Last Updated: September 5, 2025, 2:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:57 pm

Below is a detailed analysis of the balance sheet data for AKI India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.71 Cr.. The value appears strong and on an upward trend. It has increased from 17.15 Cr. (Mar 2024) to 17.71 Cr., marking an increase of 0.56 Cr..
• For Reserves, as of Mar 2025, the value is 47.18 Cr.. The value appears strong and on an upward trend. It has increased from 42.42 Cr. (Mar 2024) to 47.18 Cr., marking an increase of 4.76 Cr..
• For Borrowings, as of Mar 2025, the value is 19.17 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 18.07 Cr. (Mar 2024) to 19.17 Cr., marking an increase of 1.10 Cr..
• For Other Liabilities, as of Mar 2025, the value is 26.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.70 Cr. (Mar 2024) to 26.03 Cr., marking an increase of 1.33 Cr..
• For Total Liabilities, as of Mar 2025, the value is 110.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.34 Cr. (Mar 2024) to 110.09 Cr., marking an increase of 7.75 Cr..
• For Fixed Assets, as of Mar 2025, the value is 11.63 Cr.. The value appears to be declining and may need further review. It has decreased from 12.73 Cr. (Mar 2024) to 11.63 Cr., marking a decrease of 1.10 Cr..
• For CWIP, as of Mar 2025, the value is 8.77 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2024) to 8.77 Cr., marking an increase of 1.77 Cr..
• For Investments, as of Mar 2025, the value is 2.59 Cr.. The value appears strong and on an upward trend. It has increased from 2.48 Cr. (Mar 2024) to 2.59 Cr., marking an increase of 0.11 Cr..
• For Other Assets, as of Mar 2025, the value is 87.10 Cr.. The value appears strong and on an upward trend. It has increased from 80.13 Cr. (Mar 2024) to 87.10 Cr., marking an increase of 6.97 Cr..
• For Total Assets, as of Mar 2025, the value is 110.09 Cr.. The value appears strong and on an upward trend. It has increased from 102.34 Cr. (Mar 2024) to 110.09 Cr., marking an increase of 7.75 Cr..

Notably, the Reserves (47.18 Cr.) exceed the Borrowings (19.17 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for AKI India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 5. It has increased from 0.16 (Mar 24) to 0.19, marking an increase of 0.03.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 5. It has increased from 0.16 (Mar 24) to 0.19, marking an increase of 0.03.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 3. It has increased from 0.37 (Mar 24) to 0.39, marking an increase of 0.02.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 7.36. It has increased from 6.96 (Mar 24) to 7.36, marking an increase of 0.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 7.36. It has increased from 6.96 (Mar 24) to 7.36, marking an increase of 0.40.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 9.14. It has increased from 8.27 (Mar 24) to 9.14, marking an increase of 0.87.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 2. It has increased from 0.64 (Mar 24) to 0.71, marking an increase of 0.07.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.51. This value is within the healthy range. It has increased from 0.43 (Mar 24) to 0.51, marking an increase of 0.08.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 0.30, marking an increase of 0.09.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 2. It has increased from 0.15 (Mar 24) to 0.18, marking an increase of 0.03.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 2. It has increased from 0.15 (Mar 24) to 0.18, marking an increase of 0.03.
• For PBDIT Margin (%), as of Mar 25, the value is 7.86. This value is below the healthy minimum of 10. It has increased from 7.83 (Mar 24) to 7.86, marking an increase of 0.03.
• For PBIT Margin (%), as of Mar 25, the value is 5.63. This value is below the healthy minimum of 10. It has increased from 5.22 (Mar 24) to 5.63, marking an increase of 0.41.
• For PBT Margin (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 10. It has increased from 2.64 (Mar 24) to 3.29, marking an increase of 0.65.
• For Net Profit Margin (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 5. It has increased from 1.92 (Mar 24) to 2.07, marking an increase of 0.15.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 8. It has increased from 1.92 (Mar 24) to 2.07, marking an increase of 0.15.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 15. It has increased from 2.28 (Mar 24) to 2.57, marking an increase of 0.29.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.66. This value is below the healthy minimum of 10. It has increased from 6.08 (Mar 24) to 6.66, marking an increase of 0.58.
• For Return On Assets (%), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 5. It has increased from 1.31 (Mar 24) to 1.46, marking an increase of 0.15.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 24) to 0.05, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has decreased from 0.30 (Mar 24) to 0.29, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.74. It has decreased from 0.84 (Mar 24) to 0.74, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.77. This value is within the healthy range. It has increased from 1.63 (Mar 24) to 1.77, marking an increase of 0.14.
• For Quick Ratio (X), as of Mar 25, the value is 1.10. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.10, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.53. This value is below the healthy minimum of 4. It has decreased from 1.64 (Mar 24) to 1.53, marking a decrease of 0.11.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.36. This value is within the healthy range. It has increased from 3.04 (Mar 24) to 3.36, marking an increase of 0.32.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 3. It has increased from 1.75 (Mar 24) to 1.89, marking an increase of 0.14.
• For Enterprise Value (Cr.), as of Mar 25, the value is 88.18. It has decreased from 190.87 (Mar 24) to 88.18, marking a decrease of 102.69.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 2.69 (Mar 24) to 1.09, marking a decrease of 1.60.
• For EV / EBITDA (X), as of Mar 25, the value is 13.84. This value is within the healthy range. It has decreased from 34.36 (Mar 24) to 13.84, marking a decrease of 20.52.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 2.46 (Mar 24) to 0.88, marking a decrease of 1.58.
• For Price / BV (X), as of Mar 25, the value is 1.10. This value is within the healthy range. It has decreased from 2.92 (Mar 24) to 1.10, marking a decrease of 1.82.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 2.46 (Mar 24) to 0.88, marking a decrease of 1.58.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness